new glp 1 drugs in development Sometimes innovation comes before the ecosystem is ready. Nearly 15 years ago, researchers at Zydus Lifesciences developed an oral GLP-1 agonist (ZYOG1) and even received approval for Phase I clinical trials GLP-1 Agonists Weight Loss Drugs

Selain itu, zat ini juga mencegah terjadinya penyumbatan pembuluh darah akibat tingginya kadar kolesterol

doi: 10.1007/BF02064202

Funding This work was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0506705), National Science and Technology Major Project (2023YFC3502601), Henan Province Science and Technology Innovation Leading Talent Support Project (254200510041), Henan Provincial Science and Technology Research and Development Plan Joint Fund (Advantageous Discipline Cultivation Category) Project (232301420088)

The manufacturer claims that it can reduce the appearance of dark spots, blemishes, and uneven skin tone, as well as improving the overall health and radiance of the skin

One significant concern is the potential for treatment discontinuation due to cost, drug shortage, or adverse effects, which can lead to a deterioration in key cardiometabolic parameters, including glycemic control, blood pressure, and cholesterol levels